| Literature DB >> 31242796 |
Lily W Zhou1, William J Panenka2,3,4, Andrea A Jones2, Kristina M Gicas5, Allen E Thornton5, Manraj K S Heran6, David Volders6, Donna J Lang6, Alexandra Talia Vertinsky6, Alexander Rauscher7, Wayne Su2, Alasdair M Barr8, Gordon William MacEwan2, William G Honer2, Thalia S Field1.
Abstract
Background Homeless and vulnerably housed individuals are at increased risk for multimorbidity compared with the general population. We assessed prevalence of brain infarcts on neuroimaging and associations with vascular risk factors and cognitive performance in a prospective study of residents living in marginal housing. Methods and Results Two hundred twenty-eight participants underwent structured clinical interviews, targeted clinical, laboratory, and neuropsychological assessments, and magnetic resonance imaging with T1, T2-fluid-attenuated inversion recovery and susceptibility-weighted images. Subjects underwent cognitive testing to assess premorbid IQ , verbal learning and memory, inhibition, sustained attention, mental flexibility, and decision making. In this sample (mean age 44.0 years [ SD 9.4], 77% male), prevalence of conventional vascular risk factors was lower than in the general population apart from tobacco use (94%). Ten-year Framingham risk for any cardiovascular event was 11.4%±9.2%. Brain infarcts were present in 25/228 (11%). All were ischemic (40% cortical, 56% lacunar, 4% both). Participants with infarcts were older than those without (48.9±9.4 versus 43.4±9.2, P=0.006). In a multivariable regression analysis, only age remained a significant predictor of brain infarcts (odds ratio 1.08, 95% CI 1.02-1.14, P=0.004). After controlling for age and education, the presence of infarct was a significant predictor of impaired decision making on the Iowa Gambling Task of decision making (β -28.2, 95% CI -42.7 to -14.1, P<0.001). Conclusions Prevalence of infarcts on neuroimaging in this disadvantaged, community-dwelling cohort was much higher than expected for age and was associated with impaired decision making. Further research is needed to identify individuals at highest risk who may benefit from targeted preventative strategies.Entities:
Keywords: cognition; drug abuse; health disparities; homeless people; infarct or infarction
Mesh:
Year: 2019 PMID: 31242796 PMCID: PMC6662377 DOI: 10.1161/JAHA.118.011412
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Participant Demographics
| No Infarct on Imaging (N=203) | Infarct on Imaging (N=25) | Canadian Population 2011 | |
|---|---|---|---|
| Age (y) (missing=0) | |||
| Mean | 43.4 (SD 9.2) | 48.9 (SD 9.4) | |
| Range | 23.3–63.2 | 33–62.4 | |
| Sex (missing=0) | |||
| Male | 156/203 (77%) | 20/25 (80%) | 51% |
| Race‐ethnicity | |||
| White | 118/203 (58%) | 15/25 (60%) | 67.3% |
| First Nations | 63/203 (31%) | 6/25 (24%) | 2.1% |
| First Nation Mixed | 12/203 (6%) | 1/25 (4%) | 0.9% |
| Other | 9/203 (4%) | 3/25 (12%) | 30.1% |
| Monthly income, Canadian $ (missing=4) | |||
| Median | $871 (SD 538) | $919 (SD 476) | $2150 |
| Range | $200–$5600 | $235–$2700 | |
| History of homelessness (missing=3) | |||
| Yes | 154/201 (76.6%) | 11/24 (46%) | |
| Total y of homeless (missing=4) | |||
| Mean | 3.4 (SD 5.4) | 1.8 (SD 3.16) | |
| Range | 0–39 y | 0–11.4 y | |
| Highest educational attainment (missing=0) | |||
| 0–8 y | 39/203 (19%) | 6/25 (24%) | 6.4% |
| 8–11 y | 112/203 (55%) | 14/25 (56%) | 13.4% |
| 12 y | 28/203 (14%) | 4/25 (16%) | 19.8% |
| >12 y | 24/203 (12%) | 1/25 (4%) | 60.4% |
| Body mass index (missing=4) | |||
| Mean | 22.8 (SD 4.2) | 23.6 (SD 3.6) | |
| ≥25 | 45/203 (22%) | 7/25 (28%) | 34.1% |
| ≥30 | 0 | 0 | 18.4% |
| HgA1c (missing=8) | |||
| ≥6.5% | 3/195 (1.5%) | 1/25 (4%) | |
| ≥7.0% | 2/195 (1%) | 1/25 (4%) | |
| Self‐reported diabetes mellitus (missing=8) | |||
| Yes | 7/196 (3.6%) | 3/24 (13%) | 6.1% |
| LDL cholesterol in mmol/L (missing=11) | |||
| Mean | 2.2 (SD 0.83) | 2.5 (SD 0.96) | |
| ≥2 mmol/L | 99/192 (52%) | 16/25 (64%) | |
| ≥3.5 mmol/L | 14/192 (7.3%) | 3/25 (12%) | |
| Self‐reported dyslipidemia (missing=9) | |||
| Yes | 3/195 (1.5%) | 1/24 (4.2%) | |
| Systolic blood pressure (missing=45) | |||
| Mean (mm Hg) | 115 (SD 13.8) | 117 (SD 13.1) | |
| ≥130 mm Hg | 22/164 (13.4%) | 3/19 (16%) | |
| ≥140 mm Hg | 8/164 (4.8%) | 1/19 (5%) | |
| Diastolic blood pressure (missing=45) | |||
| Mean (mm Hg) | 75 (SD 11.3) | 78 (SD 8.5) | |
| ≥80 mm Hg | 47/164 (25.7%) | 9/19 (47%) | |
| ≥90 mm Hg | 16/164 (8.7%) | 2/19 (10.5%) | |
| Self‐reported hypertension (missing=9) | |||
| Yes | 12/199 (6%) | 4/25 (16%) | 17.6% |
| Pack y (missing=1) | |||
| Mean | 19.6 (SD 15.9) | 27.8 (SD 26.6) | |
| Range | 0–111 | 0–109 | |
| >10 pack‐y | 138/202 (68%) | 19/25 (76%) | |
| Active smoker (missing=1) | |||
| Yes | 191/202 (94.6%) | 22/25 (88%) | 19.9% |
| History of regular use of injected drugs (missing=1) | |||
| Yes | 165/202 (81.7%) | 22/25 (88%) | |
| History of alcohol dependence (missing=1) | |||
| Yes | 95/202 (47%) | 15/25 (60%) | |
| History of marijuana dependence (missing=1) | |||
| Yes | 92/202 (46%) | 11/25 (44%) | |
| HIV status (missing=0) | |||
| HIV not on ARV | 13/203 (6.4%) | 1/25 (4%) | |
| HIV on ARV | 22/203 (11.3%) | 3/25 (8%) | |
| Hepatitis C virus status (missing =9) | |||
| Ab pos, PCR neg | 35/195 (18%) | 3/24 (13%) | |
| PCR positive | 99/195 (51%) | 13/24 (54%) | |
| Hepatitis B virus status (missing=3) | |||
| Core ab positive | 74/200 (38%) | 12/25 (48%) | |
| Surface ag positive | 3/200 (1.5%) | 0/25 | |
| Modified Charlson score (missing=0) | |||
| Mean | 3.47 (SD 2.99) | 3.44 (SD 2.79) | |
| 0 | 35/203 (17%) | 3/25 (12%) | |
| ≥5 | 60/203 (30%) | 7/25 (28%) | |
| Global assessment of function (missing=0) | |||
| Mean | 38 (SD 35) | 35 (10.2) | |
| Range | 15–70 | 19–58 | |
| Estimate of IQ (WTAR | |||
| Mean | 96 (SD 8.6) | 97 (SD 9.9) | |
| Range | 75–122 | 78–113 | |
| 10‐y Framingham CVD (excluded 23 for age ≤30 y, missing component 38) | |||
| Mean | 10.9 (SD 8.5%) | 15.4 (SD 13.0%) | |
| <10% | 92/148 (62%) | 8/19 (42%) | |
| 10%–20% | 56/148 (38%) | 11/19 (58%) | |
| >20% | 22/148 (15%) | 5/19 (26%) | |
| Range | 1.2%–44.4% | 1.7%–48.9% | |
HgA1c indicates hemoglobin A1c; ARV, antiretroviral drugs; CVD, cardiovascular disease; PCR, polymerase chain reaction; WTAR, Wechsler Test of Adult Reading.
Reported for Vancouver, BC; proportions of individuals by ethnicity are highly variable between different Canadian cities.
Based on annual income of unattached individuals.
Prevalence of Infarcts on MRI
| Infarct on Baseline Imaging | No Infarct | |
|---|---|---|
| Self‐reported history of stroke | 2 | 7 |
| No reported history of stroke | 23 | 193 |
| Missing | 0 | 3 |
MRI indicates magnetic resonance imaging.
Figure 1Infarct morphology.
Substance Use and Infarct Morphology
| Years of Substance Use | |||||||
|---|---|---|---|---|---|---|---|
| Alcohol | Cannabis | Cocaine | Amphetamine | Hallucinogen | Opiate | IVDU | |
| Cortical (n=9) | |||||||
| Median | 5 | 10 | 7.5 | 0.5 | 0 | 0 | 3.5 |
| Mean | 9.50 | 13.78 | 9.94 | 4.50 | 1.86 | 3.94 | 5.38 |
| Lacunar (n=14) | |||||||
| Median | 20 | 4.5 | 10 | 3.5 | 0 | 6 | 20 |
| Mean | 18.09 | 8.79 | 14.45 | 4.65 | 0.50 | 12.75 | 20.36 |
|
| 0.364 | 0.734 | 0.904 | 0.962 | 0.837 | 0.11 | 0.041 |
IVDU indicates intravenous drug use.
Univariate Risk Factor Comparisons
| Variable | No Infarct on Imaging | Infarct on Imaging | Univariate Comparisons | |
|---|---|---|---|---|
| (N=203) | (N=25) | |||
| Age (missing =0) | Mean (y) | 43.4 (SD 9.2) | 48.9 (SD 9.4) | T Score=−2.818, |
| Sex (missing=0) | ||||
| Male | 156/203 (77%) | 20/25 (80%) | χ2=0.126, | |
| Race‐ethnicity (missing=0) | ||||
| White | 118/203 (58%) | 15/25 (60%) | χ2=2.929, | |
| First Nations | 63/203 (31%) | 6/25 (24%) | ||
| First Nation mixed | 12/203 (6%) | 1/25 (4%) | ||
| Other | 9/203 (4%) | 3/25 (12%) | ||
| Total y of homeless (missing=4) | Median | 1.3 (IQR 5) | 0 (IQR 2) | Z score=−2.341, |
| Highest educational attainment (missing=0) | Median | 10 (IQR 3) | 10 (IQR 3) | Z score=−0.981, |
| Body mass index (missing=4) | Median | 22.2 (IQR 4.1) | 22.9 (4.7) | Z score=−1.288, |
| HgA1c (missing=8) | Median | 5.5 (IQR 0.5) | 5.4 (IQR 0.6) | Z score=−0.117, |
| LDL cholesterol (missing=11) | Median (mmol/L) | 2.1 (SD 1.1) | 2.5 (IQR 1.3) |
|
| Systolic blood pressure (missing=45) | Median (mm Hg) | 114 (IQR 18) | 121 (IQR 16) |
|
| Diastolic blood pressure (missing=45) | Median (mm Hg) | 75 (IQR 12) | 81 (IQR 13) |
|
| Pack y (missing=1) | Median | 17.0 (IQR 22.5) | 16.8 (IQR 17.9) |
|
| History of regular use of injected drugs (missing=1) | Yes | 165/202 (81.7%) | 22/25 (88%) | χ2=0.737, |
| History of alcohol dependence (missing=1) | Yes | 95/202 (47%) | 15/25 (60%) | χ2=1.628, |
| History of marijuana dependence (missing=1) | Yes | 92/202 (46%) | 11/25 (44%) | χ2=0.145, |
| HIV status (missing=0) | ||||
| HIV not on ARV | 13/203 (6.4%) | 1/25 (4%) | χ2=0.241, | |
| HIV on ARV | 22/203 (11.3%) | 3/25 (8%) | ||
| HCV status (missing =9) | ||||
| Ab pos, PCR neg | 35/195 (18%) | 3/24 (13%) | χ2=0.442, | |
| PCR pos | 99/195 (51%) | 13/24 (54%) | ||
| HBV status (missing=3) | ||||
| Core ab positive | 74/200 (38%) | 12/25 (48%) | χ2=1.801, | |
| Surface ag positive | 3/200 (1.5%) | 0/25 | ||
| Modified Charlson Score (missing=0) | Median | 3 (IQR 4) | 4 (IQR 5) | Z score=−0.264, |
HgA1c indicates hemoglobin A1c; ARV, antiretroviral drugs; IQR, interquartile range; HBV, hepatitis B virus; HCV, hepatitis C virus; PCR, polymerase chain reaction.
T scores; independent samples t test.
Z scores; Mann–Whitney U test for continuous variable felt to have significant deviations from normal distribution.
χ2 for comparison of frequencies.
Neurocognitive Testing
| Stroop | Delayed Hopkins Verbal Learning Test | Rapid Visual Information Processing | Iowa Gambling Task | Log Transformed Intra‐Dimensional Extra‐Dimensional Set Shift | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Infarct − | Infarct + | − | + | − | + | − | + | − | + | |
| N | 193 | 24 | 198 | 24 | 186 | 24 | 180 | 23 | 193 | 24 |
| Mean | 35.99 | 31.83 | 6.09 | 5.96 | 0.87 | 0.84 | −1.50 | −30.70 | −1.58 | −1.73 |
| SD | 10.01 | 10.99 | 2.85 | 3.11 | 0.06 | 0.06 | 32.36 | 24.92 | 0.38 | 0.28 |
| Model 1 | 0.099 | 0.054 (0.0537) | 0.056 | 0.012 | 0.116 | |||||
| Model 2 | 0.104 | 0.054 (0.0544) | 0.064 | 0.084 | 0.121 | |||||
| ∆ | 0.005 | 0.0007 | 0.009 | 0.072 | 0.004 | |||||
| ∆ | 0.291 | 0.690 | 0.167 | <0.001 | 0.300 | |||||
| Age | B=−0.226 (95% CI −0.371 to −0.081), | B=−0.054 (95% CI −0.095 to −0.014), | B=−0.001 (95% CI −0.002 to 0.000), | B=−0.122 (95% CI −0.600 to 0.356), | B=−0.011 (95% CI −0.016 to −0.006), | |||||
| Education | B=1.094 (95% CI 0.493 to 1.694), | B=−0.204 (95% CI −0.039 to 0.369), | B=0.004 (95% CI 0.001 to 0.007), | B=0.900 (95% CI −1.051 to 2.851), | B=0.032 (95% CI 0.011 to 0.054), | |||||
| Presence of infarct | B=−2.278 (95% CI −6.518 to 1.963), | B=0.247 (95% CI −0.974 to 1.469), | B=−0.018 (95% CI −0.043 to 0.008), | B=−28.204 (95% CI −42.270 to −14.138), | B=−0.081 (95% CI −0.235 to 0.073), | |||||
Adjusted for age and education.